A homozygous p.Glu150Lys mutation in the opsin gene of two Pakistani families with autosomal recessive retinitis pigmentosa. by Azam, M. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/81313
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
A homozygous p.Glu150Lys mutation in the opsin gene of two
Pakistani families with autosomal recessive retinitis pigmentosa
Maleeha Azam,1,2 Muhammad Imran Khan,1 Andreas Gal,3 Alamdar Hussain,1 Syed Tahir Abbas Shah,1
Muhammad Shakil Khan,1,4 Ahmed Sadeque,1 Habib Bokhari,1 Rob W.J. Collin,2,5 Ulrike Orth,3
Maria M. van Genderen,6 A.I. den Hollander,2,5 Frans P. M. Cremers,1,2,5 Raheel Qamar1,4
1Department of Biosciences, COMSATS Institute of Information Technology, Islamabad, Pakistan; 2Department of Human Genetics,
Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 3Department of Human Genetics, University Medical
Centre Hamburg Eppendorf, Germany; 4Shifa College of Medicine, Islamabad, Pakistan; 5Nijmegen Centre for Molecular Life
Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; 6Bartiméus Institute for the Visually Impaired,
Zeist, The Netherlands
Purpose: To identify the gene mutations responsible for autosomal recessive retinitis pigmentosa (arRP) in Pakistani
families.
Methods: A cohort of consanguineous families with typical RP phenotype in patients was screened by homozygosity
mapping using microsatellite markers that mapped close to 21 known arRP genes and five arRP loci. Mutation analysis
was performed by direct sequencing of the candidate gene.
Results: In two families, RP21 and RP53, homozygosity mapping suggested RHO, the gene encoding rhodopsin, as a
candidate disease gene on chromosome 3q21. In six out of seven affected members from the two families, direct sequencing
of RHO identified a homozygous c.448G>A mutation resulting in the p.Glu150Lys amino acid change. This variant was
first reported in PMK197, an Indian arRP family. Single nucleotide polymorphism analysis in RP21, RP53, and PMK197
showed a common disease-associated haplotype in the three families.
Conclusions: In two consanguineous Pakistani families with typical arRP phenotype in the patients, we identified a
disease-causing mutation (p.Glu150Lys) in the RHO gene. Single nucleotide polymorphism analysis suggests that the
previously reported Indian family (PMK197) and the two Pakistani families studied here share the RHO p.Glu150Lys
mutation due to a common ancestry.
Retinitis pigmentosa (RP) is a clinically and genetically
heterogeneous group of ophthalmic diseases that are
characterized by night blindness and gradual loss of peripheral
vision due to a progressive degeneration of the photoreceptor
cells in the retina. RP is a major cause of inherited blindness
in adulthood, with a worldwide prevalence of 1 in 3,500–
4,000 individuals [1-4]. The diagnosis of individuals affected
by RP is typically based on fundus examination and the
electroretinogram (ERG). In affected individuals, the fundus
shows a waxy pallor of the optic discs, retinal vessel
attenuation, and peripheral pigmentary alterations with bone
spicule deposits. The ERG typically shows a photoreceptor
dysfunction with the rod-derived responses being more
affected than the cone-derived ones [5]. In addition to clinical
heterogeneity of RP, there is a significant genetic
heterogeneity of the disease, with different modes of
inheritance [6-8]. To date more than 40 different RP-
associated genes have been identified (RetNet). These genes
encode proteins that are involved either in the
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phototransduction cascade, retinoid metabolism, cell–cell
interaction, or photoreceptor development. Some of these
proteins are transcription or splicing factors, whereas others
are intracellular transport molecules [9,10].
Rhodopsin is an abundant rod photoreceptor-specific
transmembrane protein, which upon photoexcitation initiates
the phototransduction cascade. Heterozygous mutations of the
corresponding gene (RHO; MIM 180380) account for
approximately 30% of all autosomal dominant RP (adRP)
cases in the USA and the UK, whereas the relative frequency
and prevalence of RHO mutations is uncertain in the Asian
population [11,12]. Up to now there have been more than 100
adRP-causing mutations, but only two autosomal recessive
RP-associated mutations have been reported in the coding
sequence of RHO (RetNet) [13-15]. The first arRP case, a
French-Canadian female patient, carried an apparently
homozygous null mutation in exon 4 [14], whereas in the
second case, in a consanguineous Indian family, a
homozygous c.448G>A (p.Glu150Lys) mutation in exon 2
was reported [15]. Here we report the identification of the
p.Glu150Lys RHO mutation in affected individuals from two
Pakistani families with arRP.
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METHODS
Family collection: A total of 29 arRP families representative
of the autosomal recessive form of the disease were selected
from different areas of northern and central Pakistan.
Pedigree analysis and clinical ophthalmic examination: After
an initial linkage analysis, described below, two
consanguineous Pakistani families were ascertained; RP21
was from Dera Ghazi Khan (central Pakistan) and family
RP53, which was identified later during control panel
screening for the RHO mutation, was from Abbottabad
(northern Pakistan). Affected individuals had typical RP
symptoms with early onset of night blindness. Medical and
family histories of the participants were then obtained with
the help of a questionnaire, and the pedigree structure was
drawn (Figure 1) [16]. Clinical examination and
characterization of the affected and unaffected individuals
was done by an experienced ophthalmologist. For this
purpose, individuals IV-1 and IV-7 of RP21 and V-1 and V-3
of RP53 were then selected for further detailed investigations,
including funduscopy of the retina and ERG studies.
Ethics committee approval: This study adhered to the tenets
of the Declaration of Helsinki. The consent of both families
was obtained for this study, which was approved by the Shifa
College of Medicine, Shifa International Hospital Ethics
Committee Institutional Review Board after an extensive
review of the protocol.
Sample collection and DNA isolation: Peripheral blood
samples of each individual, for which haplotypes are depicted
in Figure 1, except RP21-III-6 were drawn by 10 ml sterile
syringes (Terumo Co. BL, Philipines) and were collected
using vacutainer tubes containing acid citrate dextrose
(Becton Dickinson, Franklin Lakes, NJ). All the blood
samples were stored at 4 °C till processed further. Blood
samples of 100 random, unrelated, healthy control individuals
were also collected and stored as above for determination of
allele frequency in the general Pakistani population. Genomic
DNA was isolated using an organic phenol-chloroform
extraction method [17,18], briefly the protocol consisted of
cell lysis and protein digestion followed by phenol-
chloroform extraction of the peptides, and precipitation of
DNA with ethanol. The precipitated DNA was re-suspended
in Tris-EDTA buffer and stored at 4 °C before use.
Linkage mapping and haplotype analysis of arRP genes: To
find the causative gene in the arRP families, homozygosity
mapping using polymorphic microsatellite markers for the
known arRP loci was performed. Microsatellite markers
mapped by the Cooperative Human Linkage Center were
obtained from Invitrogen, Inc. (Carlsbad, CA). Cytogenetic
locations of these markers as well as the length of the
amplified products were obtained from the Human Genome
Database and the Marshfield Medical Center database. Table
1 lists the arRP genes and loci with the flanking markers used
for homozygosity mapping. Each microsatellite marker was
amplified in a 25-μl volume consisting of the following:
0.5 mM deoxynucleotide triphosphates (dNTPs), 1X Taq
Buffer (10 mM Tris-HCl, pH 9.0, 50 mM KCl, 0.1% Triton
X-100, 0.01% [w/v] gelatin), 1.5 mM MgCl2, 0.3 μM of each
forward and reverse primer, 2.5 U Taq polymerase, and 50 ng
genomic DNA. The thermal cycling conditions were as
follows: initial denaturation of 90 °C for 2 min, followed by
40 cycles of 90 °C for 1 min, 55 °C for 1 min, 72 °C for 1 min,
and a final extension at 72 °C for 7 min. Genotypes were
defined following PCR and 8% PAGE. Images of the gels
were visualized by UV transillumination after staining with
ethidium bromide, captured with a digital camera, and
documented using the software BioCap MW Version 11.01
software from Vilber Lourmat (Marne-La-Vallee Cedex1,
France). Haplotypes were constructed based upon the allelic
patterns of microsatellites.
After suggestive linkage was observed, additional
flanking markers were selected from the above mentioned
databases, and haplotypes were constructed for two
generations in both the pedigrees. The Lod score analysis of
all the genotyped individuals for family RP21 (excluding
RP21-III-6 for whom the haplotype was logically deduced)
for the markers was performed with the EasyLinkage software
package version 5.02 (Friedrich Alexander University
Erlangen, Nuremberg, Germany) [19].
Sequence analysis of RHO: The sequencing primers for
RHO were designed for the upstream promoter sequence and
the five coding exons with Primer3 software (Whitehead
Institute for Biomedical Research, Cambridge, MA; Table 2).
All exons of the RHO gene were bidirectionally sequenced
with an automated DNA sequencer.
Statistical analysis: Genotype frequencies of cases and
controls were compared to determine association/correlation,
and chi-square (χ2) tests were performed at the 95%
confidence interval to calculate the difference between the
observed and the expected frequencies of the variant.
Founder effect detection: To determine the status of any
founder effect in the Pakistani families RP21 and RP53 and
the Indian family PMK197, microsatellite and single
nucleotide polymorphism (SNP) analysis were performed in
all three families. Informative SNPs surrounding the RHO
gene were selected, using the UCSC genome browser
(University of California Santa Cruz, Santa Clara, CA) and
haplotypes were constructed for all three families (Figure 2).
RESULTS
In family RP21, there are four generations with five affected
individuals in the fourth generation (Figure 1A), suggesting
that RP has an autosomal recessive inheritance pattern (Figure
1). The onset of RP in this family was in the first decade, with
typical symptoms of the disease including night blindness and
progressive visual field loss. Fundus examination of the
affected members of the family revealed typical features of
Figure 1. Pedigrees and 3q21 marker haplotypes spanning the RHO gene in autosomal recessive retinitis pigmentosa families RP21 (A) and
RP53 (B). A: Family RP21 consists of four generations. White circles represent unaffected females, filled circles affected females, white
squares unaffected males, and filled squares affected males. Deceased individuals are shown with a slanting line across the symbol. Also
shown are the marker loci and their positions in an 18.5-Mb interval, which were used for fine mapping of the disease locus. Marker allele
sizes were not accurately determined and therefore we only give two-allele designations. Arrowheads designate crossovers that define the
6.8-Mb minimal critical region between D3S1589 and D3S2322. B: Family RP53 consists of five generations. Patient V-3 in one branch of
the family is homozygous for marker alleles flanking RHO. The disease in affected individual III-12 could be RHO unrelated, suggesting
locus heterogeneity in the different branches of the family. Haplotypes were established for all individuals for which marker alleles are depicted,
except for RP21-III-6, the haplotypes of whom were deduced (indicated with brackets around the haplotypes).
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RP, including optic disc pallor, attenuation of the retinal
vessels, atrophy of the peripheral retinal pigment epithelium
(RPE), and formation of bone spicule pigmentation. In
addition, affected individuals had macular edema in the
posterior pole and small white dots in the mid-periphery at the
level of the RPE (Figure 3). The ERG showed unrecordable
rod and cone responses with undetectable 30-Hz flicker ERG
(data not shown). In contrast, in unaffected individuals the
fundus was completely normal and the rod response and the
mixed rod–cone response had normal amplitudes and implicit
times, with normal oscillatory potentials (data not shown).
Single flash photopic ERG and photopic 30-Hz flicker
responses were also normal, thus the ERG pattern was
unremarkable in these individuals.
Homozygosity mapping by microsatellite marker
analysis for family RP21 excluded all reported loci for arRP
but RHO (Table 1), for which homozygosity was seen in all
five affected individuals for all flanking markers. The flanking
TABLE 1. MICROSATELLITE MARKER ALLELES FLANKING KNOWN GENES OR LOCI FOR ARRP IN SELECTED INDIVIDUALS OF FAMILIES RP21 AND RP53.
RP21 RP53
Loci Markers
Parent
III-12
Parent
III-13
Affected
IV-9
Affected
IV-10
Parent
III-6
Parent
IV-1
Affected
V-3
Affected
III-12
ABCA4 D1S406 125.5 1,2 1,2 1,2 1,2 1,2 1,2 1,2 1,2
 D1S1587 126.2 1,2 1,2 1,2 1,2 1,2 1,2 1,2 1,2
CRB1 D1S2816 211.1 1,1 1,1 1,1 1,1 1,1 1,1 1,1 1,1
 D1S1660 212.4 1,2 1,1 2,1 2,1 1,2 1,2 1,2 1,2
USH2A D1S474 233.9 1,2 1,2 1,2 1,2 1,2 1,2 1,2 1,2
 D1S2827 234.5 1,2 1,2 1,2 1,2 1,2 1,2 1,2 1,2
RPE65 D1S2806 100.4 1,2 1,3 2,1 2,1 1,1 1,1 1,1 1,1
 D1S219 101.5 1,2 1,2 2,1 2,1 2,1 1,3 1,1 2,1
RP32 D1S2808 131.9 1,2 1,1 2,1 1,1 1,2 3,1 1,1 1,2
 D1S2896 134.2 1,1 2,1 1,1 1,1 1,1 1,1 1,1 1,1
 D1S485 136.9 1,2 1,2 2,1 1,2 1,2 1,2 1,2 1,2
SAG D2S2348 242.2 2,1 1,2 1,2 1,1 1,1 1,2 1,2 1,2
 D2S2205 243 1,2 1,2 1,2 1,2 1,2 1,2 1,2 1,2
CERKL D2S2261 185.1 2,2 1,1 1,2 1,2 1,2 1,2 1,2 1,1
 D2S1391 186.2 1,2 1,1 1,2 1,1 1,1 1,2 1,2 1,2
MERTK D2S1888 121.6 1,1 1,1 1,1 1,1 1,1 1,1 1,1 1,1
 D2S1892 122.1 1,2 1,3 1,3 1,3 1,2 1,1 1,2 1,2
RP28 D2S2225 82.8 1,1 1,1 1,1 1,1 1,1 1,2 1,2 1,1
 D2S1337 85 1,2 1,2 1,2 1,2 1,2 1,2 1,2 1,2
RHO D3S3607 143.9 1,1 1,2 1,1 1,1 1,2 1,2 1,1 1,1
 D3S2322 146.6 1,2 1,2 1,1 1,1 1,2 1,2 1,1 1,2
 D3S1587 146.6 1,3 1,2 1,1 1,1 1,2 1,2 1,1 1,2
LRAT D4S1586 147 1,2 1,2 1,2 1,2 1,2 1,2 1,2 1,2
 D4S2962 152.9 1,2 1,2 1,2 1,2 1,2 1,2 1,2 1,2
CNGA1 D4S1627 60.1 1,2 1,1 1,1 1,1 1,2 1,3 1,3 1,2
 D4S3255 61.4 2,2 2,2 2,2 2,2 1,2 1,2 1,1 1,1
PDE6B D4S3360 0 1,1 1,1 1,1 1,1 1,1 1,1 1,1 1,1
 D4S2936 1.4 1,3 1,3 1,3 1,3 1,2 1,2 1,2 1,2
RP29 D4S621 175.6 1,1 1,1 1,1 1,1 1,1 1,1 1,1 1,1
 D4S415 181.3 1,1 1,1 1,1 1,1 1,1 1,2 1,1 1,2
PROM1 D4S403 25.9 1,1 1,1 1,1 1,1 1,2 1,2 1,1 1,2
 D4S3048 29.1 1,2 1,3 1,3 1,3 1,3 1,1 1,3 1,2
PDE6A D5S812 150.3 1,1 1,1 1,1 1,1 1,3 1,2 1,2 1,2
 D5S2013 152.6 1,2 1,1 1,1 1,1 1,2 1,2 1,2 1,2
TULP1 D6S265 44.4 1,2 1,2 1,2 2,1 1,2 1,3 1,2 1,3
 D6S1645 48.3 1,2 1,1 1,1 2,1 1,2 1,2 1,2 1,2
RP25 D6S257 79.9 1,2 1,2 2,1 2,1 1,2 1,2 2,1 1,2
 D6S1644 96.1 1,2 1,1 2,1 2,1 1,1 1,2 1,1 1,2
RP1 D8S509 69.4 1,2 1,1 1,1 2,1 1,2 1,2 1,2 1,2
 D8S1828 71 1,1 1,3 1,3 1,1 1,1 1,3 1,3 1,2
RGR D10S219 100.9 1,2 1,1 1,1 1,2 1,2 1,1 2,1 1,2
 D10S523 103.4 1,1 1,2 1,2 2,1 1,1 1,3 1,3 1,2
NRL D14S50 12.5 1,2 1,3 1,2 1,1 1,2 1,2 2,1 1,1
 D14S283 14 1,1 1,2 1,1 1,1 1,1 1,2 1,1 1,1
RLBP1 D15S116 85.6 1,2 1,2 1,1 2,1 1,2 1,2 1,2 1,2
 D15S996 86.8 1,2 1,3 2,1 2,1 1,2 1,1 1,1 1,2
NR2E3 D15S650 70.7 1,1 1,1 1,1 1,1 1,2 1,1 1,1 1,1
 D15S204 71.8 1,2 1,3 1,3 1,3 1,2 1,2 1,1 1,2
CNGB1 D16S3057 77.1 1,2 1,2 1,2 1,2 1,2 1,3 1,2 1,2
 D16S670 78.7 1,1 1,1 1,1 1,1 1,2 1,2 1,2 1,2
RP22 D16S403 43.8 1,3 1,2 3,1 1,2 1,1 1,2 1,2 1,2
 D16S287 48.6 1,1 1,1 1,1 1,1 1,2 1,2 1,2 1,3
PRCD D17S1848 95.9 1,1 1,2 1,2 1,1 1,2 1,2 1,1 1,2
 D17S1839 102.5 1,2 1,2 1,1 2,1 1,2 1,2 1,2 1,2
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TABLE 2. AMPLIFICATION AND SEQUENCING PRIMERS FOR RHO
Name Forward primer (5′→3′) Reverse Primer (5′→3′)
Promoter 1 CTAGCGTTCAAGACCCATTAC ACTCAGGATCCAGGAAAAGG
Promoter 1 GGACTGGATGACTCCAGAGG CCAAGAATGCTGCGAAGG
Exon 1 CTGCAGCGGGGATTAATATG GGACAGGAGAAGGGAGAAGG
Exon 2 GTTGCCTTCCTAGCTACCCTCT GCCAGGAGACATACAAGGTCAG
Exon 3 CAGCCATGCAGACGTTTATG GTCCAGACCATGGCTCCTC
Exon 4 ACGGCTCTGAGGGTCCAG AGGAATCTGCATTTCTCACACA
Exon 5a GAATCGTGAGGGGCAGAAG AAAGATGAGTTGGGAGGAGGA
Exon 5b GGGACATCCACCAAGACCTA AAAATGTTCACTATCAGGAGGTGAT
Exon 5c GGGCCTCACTTTCTTCTCCT ATAGGCCACATTGGGAAGG
Exon 5d AACCTTGGGGCAGGTTTTTA CTTGTCTGGCAAGGGAAACT
Exon 5e TCTCGAAGAGCTTAGAAACAAAGA CCCAGCCAAGGTCAGTTTTA
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markers of the RHO locus used in our study were those
described previously by Young et al. [20]. Refinement of the
marker analysis (Figure 1A) resulted in a 6.8-Mb (4.8-cM)
critical interval flanked by D3S1589 and D3S2322, with a
maximum Lod score, for all the genotyped individuals only,
of 2.6 for marker D3S3606 at a θ value of 0.00.
Direct sequencing of RHO resulted in identification of c.
448G>A, a previously reported mutation in exon 2, resulting
in the replacement of a lysine residue for a glutamic acid
(p.Glu150Lys) [15]. All affected individuals in this family
were found to be homozygous for this change, whereas all
unaffected individuals were found to be heterozygous for this
mutation (Figure 1 and Figure 4).
To determine the frequency of the c.448G>A mutation in
the general Pakistani population, exon 2 of 100 random
control samples was sequenced, which resulted in a frequency
of 0.005 of the disease allele in the general population. During
this screening of the unrelated healthy control panel, one
individual (V-1, Figure 1B) was identified as a heterozygote
of this mutation. Upon further investigation it was found that
a person with RP was also present in this family. Detailed
clinical examination of this family (RP53) confirmed the
presence of RP, with onset of night blindness in the second
decade of life in the two affected individuals. Blood samples
of selected family members were then obtained and
homozygosity mapping was conducted for the RHO locus
Figure 2. Haplotype analysis for single nucleotide polymorphisms (SNPs) in close proximity to the RHO mutation. Frequencies [26] of the
combined homozygous variants based on individual allele frequencies in the studied population are: rs789231 (CC), 0.25; RHO (AA),
0.000025; rs2855557 (AA), 0.178084; rs2625961 (GG), 0.207025.
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(Figure 1B). Homozygosity mapping and sequencing resulted
in identification of 11 heterozygotes, including the affected
individual III-12, while only one female, V-3, was
homozygous for the c.448G>A mutation. Sequencing of the
remaining exons and upstream regulatory regions of RHO in
III-12 did not reveal any additional RHO mutations.
In addition to the 100 control samples, exon 2 of the
RHO gene was also sequenced using the DNA samples of 28
probands from a Pakistani RP cohort to determine the
prevalence of the c.448G>A mutation. None of the affected
individuals were found to carry this mutation. The χ2 analysis
resulted in a significant association of the homozygous mutant
allele A (p<0.05) with the disease when calculated for all the
individuals of both the families and also when compared with
the control samples (Table 3).
Founder effect analysis of the c.448G>A mutation in the
two Pakistani families (RP21, RP53) and the Indian family
(PMK197) [15] revealed that all affected members share the
same homozygous haplotype consisting of three highly
informative SNPs surrounding the RHO gene mutation
(Figure 2), therefore suggesting a common ancestry between
the three families.
DISCUSSION
Two apparently unrelated, ethnically diverse, Pakistani arRP
families from different geographical regions of Pakistan,
RP21 from the Punjab province and RP53 from the North
West Frontier province, were identified and analyzed by
homozygosity mapping using highly informative
microsatellite markers flanking the known arRP genes and
loci. Initially, one of the families (RP21) showed
homozygosity for the RHO (RP4) locus at 3q22.1 in all
affected individuals of the family.
Mutations in the rhodopsin gene have previously been
shown to result in RP. However, most of the RHO mutations
have been found in families with adRP, Human Genome
Mutation Database (HGMD, rhodopsin mutation), whereas
only two mutations have been shown to cause RP with an
autosomal recessive mode of inheritance [14,15].
In this study, we identified the c.448G>A mutation in the
RHO gene in two different consanguineous arRP families
from Pakistan and also determined the frequency of the
pathogenic allele in the normal population. While determining
the population frequency, we found the c.448G>A mutation
in the heterozygous state in one out of 100 control samples,
but we did not find it in any of the other 28 families from our
RP panel that were screened for the c.448G>A mutation.
Further investigations of the family of the heterozygous
individual from the control samples resulted in the
identification of an additional arRP family (RP53). DNA
sequencing revealed the same causative mutation in one
branch of the family. There seems to be genetic heterogeneity
Figure 3. Fundus photograph of an
individual affected with retinitis
pigmentosa. The fundus appearance of
individual RP21-IV-1 is characteristic
of advanced RP, with optic disc pallor,
attenuation of the retinal vessels,
peripheral pigment epithelial atrophy,
and bone spicule pigmentation. The
posterior pole shows macular edema,
and small white dots are present in the
mid-periphery at the level of the retinal
pigment epithelium
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of the RP in this family as individual III-12 may either carry
a second, yet unidentified, variant in the RHO intronic
sequences or a mutation in a different gene. The statistical
analysis for the association/correlation showed that the mutant
allele A is significantly associated (p<0.05) with the disease
phenotype because the AA genotype is always observed in
known affected individuals and is absent from the normal
population (Table 3, Figure 2).
This c.448G>A mutation has previously been reported to
cause arRP in an Indian family from southern India [15],
which is ethnically different and geographically isolated from
the present families. We therefore compared, in the two
Pakistani families and the Indian family, some of the SNPs
from the surrounding region of RHO to determine if they share
a haplotype, suggesting a founder mutation in these families.
Indeed, our analysis revealed a shared haplotype in the
patients of the three families, suggesting a common ancestry.
This is remarkable as the three families belong to diverse
ethnic groups and have lived at their present location for
several generations with no relative having moved to any other
part of the subcontinent, at least for the last 10 generations;
thus any commonality in ancestry must be more than several
hundred years old.
Genetic screening of RP families is not only helpful in
understanding the molecular mechanism of the disease; it is
also important for genetic counseling. Traditional
consanguineous marriages are major risk factors for
autosomal recessive diseases, including retinopathies.
Families have little knowledge of the inheritance of the
diseases, and through such studies as the present one, many
families could be counseled appropriately, as was done for
members of families RP21 and RP53.
The rod visual pigment rhodopsin consists of the
apoprotein opsin and the covalently bound chromophore 11-
cis-retinal [21]. This protein is a heptahelical G protein-
coupled receptor synthesized at a high level in the rod inner
Figure 4. Sequence analysis of RHO in family RP21. A: Sequence trace of part of exon 2 of an affected individual (RP21-IV-1) showing the
homozygous mutant sequence c.448G>A. B: Sequencing results of RP21-IV-7 showing the heterozygous c.448G>A sequence. C: Sequence
trace of an unaffected individual with the homozygous wild-type c.448G. d
TABLE 3. CHI SQUARE ANALYSIS.
A Unaffected family members Patients p (χ2)
GG/GA 20 1 <0.05 (22.04)
AA 0 6
B Controls+Unaffected family members Patients p (χ2)
GG/GA 119 1 <0.05 (107.10)
AA 0 6
A: χ2 analysis of families RP21 and RP53 showing association of alleles AA with the disease. B: χ2 analysis of the families and
the controls.
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segment and transported subsequently to the rod outer
segment [22]. The seven transmembrane segments (H1–H7)
are sequentially linked by extracellular (E1–E3) and
cytoplasmic (C1–C3) loops [23]. The first reported null
mutation (p.Glu249Ter) associated with arRP was shown to
abolish the function of the helices H6 and H7, which contains
the retinal binding site. Remarkably, this mutation caused an
abnormal ERG pattern even in heterozygotes [14].
Residue Glu150, which is embedded at the edge of the
phospholipid bilayer, is located near the C-terminal region of
the C2 loop, which is important for proper folding of opsin
and its binding to transducin and thus for the initiation of the
phototransduction cascade [24]. However, Zhu et al. [25] have
shown that the homozygous p.Glu150Lys change does not
affect binding of opsin to transducin but instead affects the
export of the protein opsin from the Golgi apparatus. This is
due to improper glycosylation of the protein, which results in
retention of the protein inside the Golgi, leading to an
insufficient supply of opsin to the rod outer segments. The
processing of rhodopsin protein has been shown to be normal
in the p.Glu150Lys heterozygotes [25].
We conclude that linkage and mutation analysis of known
retinal disease genes in Pakistani patients with RP resulted in
the identification of a RHO mutation in two out of 30 families
that very likely have a common ancestor and are also distantly
related with the Indian family previously found to harbor this
mutation. We also observed genetic heterogeneity in one of
these two families. These findings have facilitated accurate
genetic counseling of patients and unaffected family
members.
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